HELICOBACTER-PYLORI AND INCREASED EPITHELIAL-CELL PROLIFERATION - A RISK FACTOR FOR CANCER

被引:62
作者
CAHILL, RJ [1 ]
SANT, S [1 ]
BEATTIE, S [1 ]
HAMILTON, H [1 ]
OMORAIN, C [1 ]
机构
[1] MEATH HOSP,DEPT GASTROENTEROL,DUBLIN 8,IRELAND
关键词
HELICOBACTER PYLORI; GASTRIC CARCINOMA; CELL PROLIFERATION;
D O I
10.1097/00042737-199412000-00010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Epidemiological studies have identified a link between Helicobacter pylori and gastric carcinoma. Epithelial cell proliferation is an indicator of risk of adenocarcinoma. We aimed to assess the effect of H. pylori on gastric epithelial cell proliferation. Subjects: A total of 124 patients were recruited and assigned to three study groups. Group 1 (control group) comprised 28 H. pylori-negative patients with normal gastric mucosa; group 2 comprised 28 H. pylori-negative patients with type C (chemically induced) gastritis and group 3 comprised 68 H. pylori-positive patients with type B (bacteria induced) gastritis. Four antral mucosal biopsy specimens were taken for cell proliferation analysis using the in vitro bromodeoxyuridine immunohistochemical technique. Ten entire gastric pits of more than 100 cells were counted per patient and the labelling index percentage (LI%) was calculated (the total number of proliferating cells expressed as a percentage of the total number of cells per pit). Results: Patients with H. pylori-positive gastritis had a significantly higher LI% (4.5+/-0.2%; P<0.05) than patients with H. pylori-negative gastritis (3.3+/-0.2%) or controls (2.9+/-0.1%). This increased cell proliferation was not associated with the severity of inflammation or the presence or absence of an ulcer on gastroscopy. Conclusion: Increased cell proliferation was associated with H. pylori infection, which may indicate that H. pylori is a risk factor in the pathogenesis of gastric cancer.
引用
收藏
页码:1123 / 1127
页数:5
相关论文
共 31 条
  • [1] Correa P., Fox J., Fontham E., Fontham D.P.H., Ruiz B., Lin Y., Et al., Helicobacter pylori and gastric carcinoma: Serum antibody prevalence in populations with contrasting cancer risks, Cancer, 66, pp. 2569-2574, (1990)
  • [2] Fox J.G., Correa P., Taylor N.S., Zavala D., Fontham E., Janney F., Et al., Campylobacter pylori — associated gastritis and immune response in a population at increased risk of gastric carcinoma, Am J Gastroenterol, 84, pp. 775-781, (1989)
  • [3] Parsonnet J., Friedman C.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Et al., Helicobacter pylori infection and the risk of gastric carcinoma, N Engl J Med, 325, pp. 1127-1131, (1991)
  • [4] Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Et al., Gastric precancerous process in a high-risk population cohort follow-up, Cancer Res, 50, pp. 4737-4740, (1990)
  • [5] Correa P., A human model of gastric carcinogenesis, Cancer Res, 48, pp. 3554-3560, (1988)
  • [6] Deschner E.E., Winawer S.J., Lipkin M., Patterns of nucleic acid and protein synthesis in normal human gastric mucosa and atrophic gastritis, J Natl Cancer Inst, 48, pp. 1567-1574, (1972)
  • [7] Brito M.J., Filipe M.I., Morris R.W., Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine (BrdU) labelling index, Eur J Cancer Prev, 1, pp. 429-435, (1992)
  • [8] Rosa J.C., Mendes R., Filipe M.I., Morris R.W., Measurement of cell proliferation in gastric carcinoma: Comparative analysis in Ki-67 and proliferating cell nuclear antigen (PCNA), Histochem J, 24, pp. 93-101, (1992)
  • [9] Jain S., Filipe M.I., Hall P.A., Waseem N., Lane D.P., Levison D.A., Prognostic value of proliferating cell nuclear antigen in gastric cancer, Clin Pathol, 44, pp. 655-659, (1991)
  • [10] Lipkin M., Correa P., Mikol Y.B., Higgins P.J., Cuello C., Guillermo Z., Et al., Proliferative and antigenic modifications in human epithelial cells in chronic atrophic gastritis, J Natl Cancer Inst, 75, pp. 613-619, (1985)